DOSE-FINDING OF PROPRANOLOL IN COMBINATION WITH METRONOMIC FIXED ORAL CYCLOPHOSPHAMIDE BASED ON BIVARIATE EFFICACY-TOLERABILITY OUTCOME IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC ANGIOSARCOMA: A COLLABORATIVE AND INNOVATIVE PHASE I-II SEQUENTIAL TRIAL BY THE FRENCH SARCOMA GROUP (GSF/GETO):